三友医疗：预计2025年净利润为5600万元到7280万元，控股公司Implanet营业收入同比增长32.62%

Core Viewpoint - Sanyou Medical expects significant revenue and profit growth for the fiscal year 2025, driven by innovative therapies and product development [1] Financial Performance - Projected revenue for 2025 is between 535 million to 562 million yuan, representing a year-on-year growth of 17.95% to 23.9% [1] - Estimated net profit attributable to shareholders is expected to be between 56 million to 72.8 million yuan, showing a substantial increase of 388.29% to 534.78% year-on-year [1] - Net profit attributable to shareholders, excluding non-recurring gains and losses, is projected to be between 43 million to 61 million yuan, indicating a turnaround from losses to profits [1] Business Growth Drivers - The growth in performance is primarily attributed to the company's advantages in innovative therapies, which have facilitated new product development and partnerships, enhancing sales channels [1] - The ultrasound bone knife business and international operations have also experienced rapid growth, with the subsidiary Implanet reporting a revenue increase of 32.62% year-on-year [1] Future Plans - The company plans to continue its focus on therapy innovation and market expansion, aiming for regulatory approvals for related products to ensure sustainable future growth [1]